Promising Approaches to Combination HIV Prevention Programming in Concentrated Epidemics
AIDSTAR-One CASE STUDY SERIES May 2010
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...tries in the evidence-informed introduction and scale-up of holistic people-centred services for TB, comorbidities and health-related risk factors, with the goal of comprehensively addressing TB and other co-existing health conditions. It should be used in conjunction with relevant WHO guidelines. The Framework is intended for use by people working in ministries of health, other relevant line-ministries, policymakers, international technical and funding organizations, researchers, nongovernmental and civil society organizations, as well as primary care workers, specialist health practitioners, and community health workers who support the response to TB and comorbidities in both the public and private sectors.
more
UNAIDS 2016, Reference
HIV care and support taking into account the 2016 WHO consolidated guidelines
Third Stocktaking Report, 2008
Unite for Children, Unite against AIDS
In 2024, we need US$1.5 billion to provide live-saving health care to millions of people in emergencies. An alarming combination of conflict, climate-related threats and increasing economic hardship mean an estimated 166 million people require health assistance.
Principles and Target Product Criteria. Roadmap January 12, 2015
UNAIDS Joint United Nations Programme on HIV/AIDS
Cureus 16(2): e53933. DOI 10.7759/cureus.53933
Strengthening HIV prevention among most-at-risk populations (MARPs) in the Syrian Arab Republic:
Trachoma is a bacterial eye infection found in poor, isolated communities lacking basic hygiene, clean water, and adequate sanitation.
Advocacy achievements of the bridging the gaps global partners
Accessed: 17.11.2019
Towards gender - transformative HIV and TB responses